Maine to receive $155,000 in drug settlement

Posted Dec. 16, 2010, at 5:12 p.m.

AUGUSTA, Maine — State officials say Maine will receive more than $150,000 from two settlements between the U.S. Justice Department and pharmaceutical companies over the marketing of the epilepsy drug Zonegran.

The Justice Department says Irish pharmaceutical company Elan Corp. and its U.S. subsidiary, Elan Pharmaceuticals Inc., have agreed to pay more than $203 million for promoting Zonegran for uses not approved by the Food and Drug Administration.

Japanese drug marketer Eisai Inc., which bought the drug from Elan, will pay $11 million for off-label marketing of Zonegran.

Maine Attorney General Janet Mills said Maine will receive $155,000 from the two settlements based on prescriptions paid for by MaineCare.